ArticleBlood cell therapy2026
Risk Stratification of Non-Relapse Mortality After Allogeneic Hematopoietic Stem Cell Transplantation Based on Pre-Transplant Sarcopenia and HCT-CI.
Kensaku Kashima et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.